Skip to main content
. 2021 Jun 18;12:3790. doi: 10.1038/s41467-021-23948-6

Fig. 2. Enhanced lockdown capacity and antiproliferative activity of scFv–IgG constructs.

Fig. 2

a Layout of tetravalent biparatopic constructs in the scFv–IgG format, based on scFv–Fab fusions 841 and 641. Construct 241 lacked effect compared to 441 (see Supplementary Fig. 3b) b FRAP of 441 (50 mM) treated cells (n = 5 cells, error bar SEM) showed complete HER2 lockdown; untr untreated. c The effect of 441 on HER2 was further studied with single-molecule tracking experiments. Labeled Hela cells overexpressing a SNAP-tag HER2 fusion were analyzed with a TIRF-SMLM setup at room temperature. d The immobile fraction of HER2 was calculated to be 60% when analyzing single-molecule localizations of HER2 with the adapted DBSCAN algorithm. Two-sided unpaired t test with Welch’s correction demonstrated a significant difference from untreated cells (PBS only). e The additional antiproliferative activity of 441 over its parental antibody combination is seen across different cell lines and tissues (mean of n = 3), with relevant mutations indicated. The inhibitory effect of TZB, hA21G, and their combination on proliferation was only strong on certain HER2-dependent cell lines. 441, however, showed stronger reduction of viability throughout and thus a more universal response, hence indicating a benefit over the combination treatment. Source data are available in the Source Data file.